Header Logo

Connection

MICHAEL TAYLOR to Neoplasms

Back to Details
This is a "connection" page, showing publications MICHAEL TAYLOR has written about Neoplasms.
MICHAEL TAYLOR
Connection Strength
1.486
Neoplasms
  1. Amplifying natural antitumor immunity for personalized immunotherapy. Cell Res. 2022 06; 32(6):505-506.
    View in: PubMed
    Score: 0.266
  2. Nailing a Fe-rocious form of cancer. Science. 2020 07 17; 369(6501):250-251.
    View in: PubMed
    Score: 0.234
  3. Transposase-driven rearrangements in human tumors. Nat Genet. 2017 Jun 28; 49(7):975-977.
    View in: PubMed
    Score: 0.189
  4. Calculating a cure for cancer: managing medulloblastoma MATH1-ematically. Expert Rev Neurother. 2010 Oct; 10(10):1489-92.
    View in: PubMed
    Score: 0.119
  5. Gene context drift identifies drug targets to mitigate cancer treatment resistance. Cancer Cell. 2025 Sep 08; 43(9):1608-1621.e9.
    View in: PubMed
    Score: 0.082
  6. The Virtual Child. Cancer Discov. 2024 Apr 04; 14(4):663-668.
    View in: PubMed
    Score: 0.076
  7. Dual role of allele-specific DNA hypermethylation within the TERT promoter in cancer. J Clin Invest. 2021 11 01; 131(21).
    View in: PubMed
    Score: 0.064
  8. DNA Polymerase and Mismatch Repair Exert Distinct Microsatellite Instability Signatures in Normal and Malignant Human Cells. Cancer Discov. 2021 05; 11(5):1176-1191.
    View in: PubMed
    Score: 0.060
  9. Roadmap for the Emerging Field of Cancer Neuroscience. Cell. 2020 04 16; 181(2):219-222.
    View in: PubMed
    Score: 0.057
  10. The U1 spliceosomal RNA is recurrently mutated in multiple cancers. Nature. 2019 10; 574(7780):712-716.
    View in: PubMed
    Score: 0.055
  11. Application of a Neural Network Whole Transcriptome-Based Pan-Cancer Method for Diagnosis of Primary and Metastatic Cancers. JAMA Netw Open. 2019 04 05; 2(4):e192597.
    View in: PubMed
    Score: 0.053
  12. Comprehensive Analysis of Hypermutation in Human Cancer. Cell. 2017 Nov 16; 171(5):1042-1056.e10.
    View in: PubMed
    Score: 0.048
  13. Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity. Nature. 2017 03 02; 543(7643):122-125.
    View in: PubMed
    Score: 0.046
  14. Hypermutation of the inactive X chromosome is a frequent event in cancer. Cell. 2013 Oct 24; 155(3):567-81.
    View in: PubMed
    Score: 0.037
  15. The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation. Cell. 2013 May 23; 153(5):1064-79.
    View in: PubMed
    Score: 0.036
  16. International network of cancer genome projects. Nature. 2010 Apr 15; 464(7291):993-8.
    View in: PubMed
    Score: 0.029
  17. Leptomeningeal metastases from solid tumors: A Society for Neuro-Oncology and American Society of Clinical Oncology consensus review on clinical management and future directions. Neuro Oncol. 2024 Oct 03; 26(10):1781-1804.
    View in: PubMed
    Score: 0.020
  18. Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency. Nat Med. 2022 01; 28(1):125-135.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.